ANDREA VILLAREAL: Open Payments
NPI 1730337130 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 68 payments from 17 companies in 2025. Trend: 2023 $1,772 · 2024 $2,716 · 2025 $2,068
Food & beverage: $1,968Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $487 |
| Janssen Biotech, Inc. | 7 | $319 |
| UCB, Inc. | 7 | $303 |
| Incyte Corporation | 3 | $155 |
| LEO Pharma Inc. | 7 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $59 |
| Organogenesis Inc. | 2 | $56 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, DUPIXENT, BOTOX, ANZUPGO, ILUMYA.
Industry payments across NC — which companies pay providers there.
